Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer
- Type
- Retraction
- Notice date
- 6/21/2023 0:00
- Journal
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9879023
- Original paper DOI
- 10.1155/2021/8720679